Zobrazeno 1 - 10
of 90
pro vyhledávání: '"G, Borleri"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G, Dotti, R, Fiocchi, T, Motta, A, Gamba, E, Gotti, B, Gridelli, G, Borleri, C, Manzoni, P, Viero, G, Remuzzi, T, Barbui, A, Rambaldi
Publikováno v:
Transplantation. 69(5)
Solid organ transplant patients undergoing long-term immunosuppression have high risk of developing lymphomas. The pathogenesis of the late-occurring posttransplantation lymphoproliferative disorders (PTLD) have not yet been extensively investigated.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1795efbf61741d049392b6529c6eea0
https://pubmed.ncbi.nlm.nih.gov/10755511
https://pubmed.ncbi.nlm.nih.gov/10755511
Autor:
O, Spinelli, U, Giussani, G, Borleri, M, Lazzari, A, Michelato, G, Dotti, T, Barbui, A, Rambaldi
Publikováno v:
Haematologica. 85(11)
Leukemia relapse occurring in donor cells after allogeneic hematopoietic stem cell transplantation has been reported in rare cases. Cytogenetic analysis and molecular probing of variable number of tandem repeats (VNTRs) have been used to confirm this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5103536877c6e7a7a3032623465efd1c
https://pubmed.ncbi.nlm.nih.gov/11064467
https://pubmed.ncbi.nlm.nih.gov/11064467
Autor:
M, Introna, A M, Barbui, J, Golay, F, Bambacioni, R, Schirò, S, Bernasconi, F, Breviario, E, Erba, G, Borleri, T, Barbui, A, Biondi, A, Rambaldi
Publikováno v:
British journal of haematology. 103(2)
In order to develop a clinically feasible gene marking approach, we have used the recently described PINCO retroviral expression system, composed of the enhanced green fluorescence protein (EGFP) cDNA driven by Moloney MLV LTR and packaged in the Pho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::39fea8a766b9ea7fd13ef0ee8e620ab9
https://pubmed.ncbi.nlm.nih.gov/9827919
https://pubmed.ncbi.nlm.nih.gov/9827919
Autor:
R, Bassan, R, Raimondi, T, Lerede, A, D'emilio, M, Buelli, G, Borleri, A, Personeni, P, Bellavita, F, Rodeghiero, T, Barbui
Publikováno v:
Haematologica. 83(7)
To assess outcome of an age-adapted post-remission strategy for adult patients with acute myelogenous leukemia (AML, FAB-M3 excluded), including autologous bone marrow transplantation (ABMT) or high-dose cytarabine (HIDAC) consolidation.AML patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cf4eb8d9c918d8d744a1e10392caf08a
https://pubmed.ncbi.nlm.nih.gov/9718868
https://pubmed.ncbi.nlm.nih.gov/9718868
Publikováno v:
Haematologica. 83(5)
High-dose cytarabine (HIDAC) and new anthracycline-type drugs (mitoxantrone, idarubicin) are the mainstay of several active regimens against relapsed and refractory acute myeloid leukemia (AML). The present study was undertaken to assess the feasibil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3f213057db303a2a729ee8ddebf11be4
https://pubmed.ncbi.nlm.nih.gov/9658726
https://pubmed.ncbi.nlm.nih.gov/9658726
Publikováno v:
Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ISBN: 9783642719622
Multidrug resistance related to functional overexpression of P-170 glycoprotein (mdr-1 gene) is often responsible for treatment failure in acute leukaemia. Attempts to restore drug sensitivity with revertants and less vulnerable drugs are underway. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2ddfe736780ae28a1446c8a16c3a50f
https://doi.org/10.1007/978-3-642-71960-8_62
https://doi.org/10.1007/978-3-642-71960-8_62
Autor:
R, Bassan, S, Cortelazzo, A, Rambaldi, P, Cornelli, G, Borleri, P, Bellavita, A, Biondi, T, Barbui
Publikováno v:
Bone marrow transplantation. 15(5)
The prognosis of AML patients who fail autologous BMT and lack a donor for a salvage allogeneic BMT is very poor. We administered an alternative drug treatment including autologous PBSC transplant to a child who relapsed with AML 4 years after a mafo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ffdeb9213be7b1467961197963f49d5
https://pubmed.ncbi.nlm.nih.gov/7670409
https://pubmed.ncbi.nlm.nih.gov/7670409
Autor:
R, Bassan, R, Battista, P, Viero, E, Pogliani, G, Rossi, G, Lambertenghi-Deliliers, A, Rambaldi, A, D'Emilio, M, Buelli, G, Borleri
Publikováno v:
Seminars in oncology. 20(6 Suppl 8)
Between June 1991 and September 1992, 80 patients with adult acute lymphoblastic leukemia (ALL) (newly diagnosed, n = 68; relapsed or refractory ALL, n = 7; lymphoid blast transformation of Philadelphia chromosome-positive chronic myelogenous leukemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fadc697f6bb978c45a5197a93340be6e
https://pubmed.ncbi.nlm.nih.gov/7507263
https://pubmed.ncbi.nlm.nih.gov/7507263